Cite
HARVARD Citation
Backlund, E. et al. (2022). Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial. Acta oncologica. pp. 869-873. [Online].